• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pyxis Oncology, Inc. - Common Stock (NQ:PYXS)

2.210 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,876
Open 2.210
Bid (Size) 2.120 (100)
Ask (Size) 2.390 (1,600)
Prev. Close 2.210
Today's Range 2.210 - 2.210
52wk Range 0.9700 - 5.550
Shares Outstanding 38,245,287
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Pyxis Oncology Reports First Quarter 2026 Financial Results and Advances MICVO Toward Key 2026 Clinical Milestones
May 14, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in Upcoming Investor Conferences
May 13, 2026
From Pyxis Oncology
Via GlobeNewswire

Performance

YTD
+92.2%
+92.2%
1 Month
+30.0%
+30.0%
3 Month
+63.7%
+63.7%
6 Month
-50.7%
-50.7%
1 Year
+106.5%
+106.5%

More News

Read More
News headline image
Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer
May 07, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
March 23, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
February 03, 2026
From Pyxis Oncology
Via GlobeNewswire
News headline image
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
January 12, 2026
From Equity Insider
Via GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
January 09, 2026
Via Chartmill
News headline image
Unusual volume stocks in Tuesday's session ↗
December 23, 2025
Via Chartmill
News headline image
Top movers in Thursday's session ↗
December 18, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Thursday's session. ↗
December 18, 2025
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
December 18, 2025
Via Chartmill
News headline image
Discover the top movers in Thursday's pre-market session. ↗
December 18, 2025
Via Chartmill
News headline image
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
December 18, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in Upcoming Investor Conferences
November 03, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Provides Business Update and Reports Third Quarter 2025 Financial Results
November 03, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings
October 13, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets
October 09, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
October 06, 2025
Via Benzinga
News headline image
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in September Investor and Industry Conferences
August 21, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports Second Quarter 2025 Financial Results and Provides Business Update
August 14, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 30, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
May 14, 2025
From Pyxis Oncology
Via GlobeNewswire
News headline image
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
April 25, 2025
From Pyxis Oncology
Via GlobeNewswire

Frequently Asked Questions

Is Pyxis Oncology, Inc. - Common Stock publicly traded?
Yes, Pyxis Oncology, Inc. - Common Stock is publicly traded.
What exchange does Pyxis Oncology, Inc. - Common Stock trade on?
Pyxis Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pyxis Oncology, Inc. - Common Stock?
The ticker symbol for Pyxis Oncology, Inc. - Common Stock is PYXS on the Nasdaq Stock Market
What is the current price of Pyxis Oncology, Inc. - Common Stock?
The current price of Pyxis Oncology, Inc. - Common Stock is 2.210
When was Pyxis Oncology, Inc. - Common Stock last traded?
The last trade of Pyxis Oncology, Inc. - Common Stock was at 05/14/26 04:00 PM ET
What is the market capitalization of Pyxis Oncology, Inc. - Common Stock?
The market capitalization of Pyxis Oncology, Inc. - Common Stock is 84.52M
How many shares of Pyxis Oncology, Inc. - Common Stock are outstanding?
Pyxis Oncology, Inc. - Common Stock has 85M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap